vs
CARRIAGE SERVICES INC（CSV）とMESA LABORATORIES INC（MLAB）の財務データ比較。上の社名をクリックして会社を切り替えられます
CARRIAGE SERVICES INCの直近四半期売上が大きい（$105.5M vs $65.1M、MESA LABORATORIES INCの約1.6倍）。CARRIAGE SERVICES INCの純利益率が高く（11.6% vs 5.6%、差は6.1%）。CARRIAGE SERVICES INCの前年同期比売上増加率が高い（8.0% vs 3.6%）。MESA LABORATORIES INCの直近四半期フリーキャッシュフローが多い（$18.0M vs $6.2M）。過去8四半期でMESA LABORATORIES INCの売上複合成長率が高い（5.1% vs 1.0%）
ジャーディン・サイクル＆キャリッジ・リミテッドは、ジャーディンズが東南アジアに展開する投資持株会社であり、現在同コングロマリットが75%の株式を保有しています。東南アジア地域における同グループの投資事業の中核拠点として機能しています。
メサラボラトリーズ社は、品質管理、校正、モニタリング向け専門機器及び関連サービスの開発・製造・販売を事業としています。医療、製薬、食品飲料、産業衛生、環境試験分野を中心に、世界中の顧客の規制遵守と運用安全のニーズに応えています。
CSV vs MLAB — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $105.5M | $65.1M |
| 純利益 | $12.3M | $3.6M |
| 粗利率 | 34.8% | 64.2% |
| 営業利益率 | 23.3% | 12.2% |
| 純利益率 | 11.6% | 5.6% |
| 売上前年比 | 8.0% | 3.6% |
| 純利益前年比 | 24.5% | 316.6% |
| EPS（希薄化後） | $0.76 | $0.65 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $105.5M | $65.1M | ||
| Q3 25 | $102.7M | $60.7M | ||
| Q2 25 | $102.1M | $59.5M | ||
| Q1 25 | $107.1M | $62.1M | ||
| Q4 24 | $97.7M | $62.8M | ||
| Q3 24 | $100.7M | $57.8M | ||
| Q2 24 | $102.3M | $58.2M | ||
| Q1 24 | $103.5M | $58.9M |
| Q4 25 | $12.3M | $3.6M | ||
| Q3 25 | $6.6M | $2.5M | ||
| Q2 25 | $11.7M | $4.7M | ||
| Q1 25 | $20.9M | $-7.1M | ||
| Q4 24 | $9.9M | $-1.7M | ||
| Q3 24 | $9.9M | $3.4M | ||
| Q2 24 | $6.3M | $3.4M | ||
| Q1 24 | $7.0M | $-254.6M |
| Q4 25 | 34.8% | 64.2% | ||
| Q3 25 | 35.3% | 61.5% | ||
| Q2 25 | 35.2% | 62.0% | ||
| Q1 25 | 35.3% | 61.8% | ||
| Q4 24 | 34.4% | 63.3% | ||
| Q3 24 | 35.2% | 61.3% | ||
| Q2 24 | 36.2% | 64.0% | ||
| Q1 24 | 36.0% | 62.1% |
| Q4 25 | 23.3% | 12.2% | ||
| Q3 25 | 17.0% | 7.8% | ||
| Q2 25 | 23.5% | 5.1% | ||
| Q1 25 | 29.5% | 2.4% | ||
| Q4 24 | 21.6% | 9.2% | ||
| Q3 24 | 22.7% | 6.1% | ||
| Q2 24 | 18.0% | 9.6% | ||
| Q1 24 | 18.8% | -460.6% |
| Q4 25 | 11.6% | 5.6% | ||
| Q3 25 | 6.4% | 4.1% | ||
| Q2 25 | 11.5% | 8.0% | ||
| Q1 25 | 19.5% | -11.4% | ||
| Q4 24 | 10.1% | -2.7% | ||
| Q3 24 | 9.8% | 5.9% | ||
| Q2 24 | 6.1% | 5.8% | ||
| Q1 24 | 6.7% | -432.2% |
| Q4 25 | $0.76 | $0.65 | ||
| Q3 25 | $0.41 | $0.45 | ||
| Q2 25 | $0.74 | $0.85 | ||
| Q1 25 | $1.34 | $-1.30 | ||
| Q4 24 | $0.62 | $-0.31 | ||
| Q3 24 | $0.63 | $0.63 | ||
| Q2 24 | $0.40 | $0.62 | ||
| Q1 24 | $0.45 | $-47.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $1.7M | $29.0M |
| 総負債低いほど良い | — | $68.4M |
| 株主資本純資産 | $254.8M | $186.7M |
| 総資産 | $1.3B | $434.8M |
| 負債/資本比率低いほどレバレッジが低い | — | 0.37× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.7M | $29.0M | ||
| Q3 25 | $1.2M | $20.4M | ||
| Q2 25 | $1.4M | $21.3M | ||
| Q1 25 | $4.6M | $27.3M | ||
| Q4 24 | $1.2M | $27.3M | ||
| Q3 24 | $1.3M | $24.3M | ||
| Q2 24 | $1.5M | $28.5M | ||
| Q1 24 | $1.7M | $28.2M |
| Q4 25 | — | $68.4M | ||
| Q3 25 | — | $69.4M | ||
| Q2 25 | — | $70.3M | ||
| Q1 25 | — | $71.3M | ||
| Q4 24 | — | $72.2M | ||
| Q3 24 | — | $73.1M | ||
| Q2 24 | — | $74.1M | ||
| Q1 24 | — | — |
| Q4 25 | $254.8M | $186.7M | ||
| Q3 25 | $242.1M | $178.5M | ||
| Q2 25 | $235.4M | $172.5M | ||
| Q1 25 | $223.1M | $159.8M | ||
| Q4 24 | $208.6M | $155.2M | ||
| Q3 24 | $198.1M | $161.5M | ||
| Q2 24 | $187.9M | $150.7M | ||
| Q1 24 | $179.6M | $145.4M |
| Q4 25 | $1.3B | $434.8M | ||
| Q3 25 | $1.3B | $430.4M | ||
| Q2 25 | $1.3B | $435.7M | ||
| Q1 25 | $1.3B | $433.3M | ||
| Q4 24 | $1.3B | $433.3M | ||
| Q3 24 | $1.3B | $454.1M | ||
| Q2 24 | $1.3B | $440.4M | ||
| Q1 24 | $1.3B | $446.8M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.49× | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $14.1M | $18.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $6.2M | $18.0M |
| FCFマージンFCF / 売上 | 5.9% | 27.7% |
| 設備投資強度設備投資 / 売上 | 7.5% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 1.15× | 5.17× |
| 直近12ヶ月FCF直近4四半期 | $40.1M | $37.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $14.1M | $18.8M | ||
| Q3 25 | $24.7M | $8.2M | ||
| Q2 25 | $8.1M | $1.9M | ||
| Q1 25 | $13.8M | $12.7M | ||
| Q4 24 | $9.3M | $18.1M | ||
| Q3 24 | $20.9M | $5.3M | ||
| Q2 24 | $2.2M | $10.7M | ||
| Q1 24 | $19.7M | $12.9M |
| Q4 25 | $6.2M | $18.0M | ||
| Q3 25 | $18.0M | $7.1M | ||
| Q2 25 | $5.2M | $884.0K | ||
| Q1 25 | $10.6M | $11.9M | ||
| Q4 24 | $4.9M | $17.3M | ||
| Q3 24 | $16.2M | $3.5M | ||
| Q2 24 | $-1.4M | $9.9M | ||
| Q1 24 | $16.2M | $12.3M |
| Q4 25 | 5.9% | 27.7% | ||
| Q3 25 | 17.5% | 11.7% | ||
| Q2 25 | 5.1% | 1.5% | ||
| Q1 25 | 9.9% | 19.2% | ||
| Q4 24 | 5.0% | 27.6% | ||
| Q3 24 | 16.1% | 6.0% | ||
| Q2 24 | -1.4% | 16.9% | ||
| Q1 24 | 15.6% | 21.0% |
| Q4 25 | 7.5% | 1.1% | ||
| Q3 25 | 6.5% | 1.8% | ||
| Q2 25 | 2.8% | 1.7% | ||
| Q1 25 | 3.0% | 1.2% | ||
| Q4 24 | 4.5% | 1.3% | ||
| Q3 24 | 4.6% | 3.1% | ||
| Q2 24 | 3.5% | 1.5% | ||
| Q1 24 | 3.4% | 0.9% |
| Q4 25 | 1.15× | 5.17× | ||
| Q3 25 | 3.76× | 3.32× | ||
| Q2 25 | 0.69× | 0.40× | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.11× | 1.54× | ||
| Q2 24 | 0.34× | 3.17× | ||
| Q1 24 | 2.83× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
